Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 35 - Antineoplastic agents
Patents for A61P 35 - Antineoplastic agents (221,099)
03/2003
03/12/2003EP1289564A2 T cell receptor fusions and conjugates and methods of use thereof
03/12/2003EP1289562A2 Novel of preparation hypericin bonded with poly-n-vinylamides
03/12/2003EP1289561A2 Ligand conjugates and methods for preparing same
03/12/2003EP1289559A1 Combinations of enzyme inhibitor-containing preparations and the use thereof
03/12/2003EP1289557A2 Cancer treatment composition containing an anti-neoplastic agent and a pde4 inhibitor
03/12/2003EP1289556A2 Phytoestrogenic isoflavone compositions
03/12/2003EP1289553A1 Nrg-2 nucleic acid molecules, polypeptides, and diagnostic and therapeutic methods
03/12/2003EP1289552A2 Methods for diagnosing and treating hemostatic disorders by modulating p-selectin activity
03/12/2003EP1289549A2 The use of plant oil-bodies in vaccine delivery systems
03/12/2003EP1289548A2 Immune system stimulating means
03/12/2003EP1289546A1 Combined preparation for the treatment of neoplasic diseases
03/12/2003EP1289541A2 Interferon for the treatment of multiple sclerosis
03/12/2003EP1289525A2 Tricyclic pyrazole derivatives as protein kinase inhibitors
03/12/2003EP1289517A2 Pharmaceutical compositions comprising cannabidiol derivatives
03/12/2003EP1289515A1 Pharmaceutical composition containing at least a polymer associated or conjugated with at least a phenylalkylcarboxylic acid salt, conjugate polymers and uses thereof
03/12/2003EP1289513A2 Use of aloe-emodin in the treatment of neuroectodermal tumors
03/12/2003EP1289509A2 Compositions containing naphthaquinone and an antiproliferative agent
03/12/2003EP1289472A2 Compositions and methods for identifying agents which modulate pten function and pi-3 kinase pathways
03/12/2003EP1097127B1 Diacylhydrazine derivatives as integrin inhibitors
03/12/2003EP0994702B1 Medicament comprising adenosine
03/12/2003EP0979098B1 Method of treating hyperprolactinemia and prolactinomas
03/12/2003EP0970098B1 Anthracycline glycosides
03/12/2003EP0964852B1 Indolecarboxylic compounds and their use as pharmaceutical compounds
03/12/2003EP0937726B1 Intermediates for the preparation of duocarmycin sa and derivatives thereof, and process for the production of the intermediates
03/12/2003EP0900198B1 New vitamin d derivatives with carbo- or heterocyclic substituents at c-25, a process for their production, intermediate products and their use for producing medicaments
03/12/2003EP0874830B1 A metalloproteinase inhibitor, a pharmaceutical composition containing it and the pharmaceutical use and method useful for the preparation thereof
03/12/2003EP0871757B1 Conditionally replicating viral vectors and their use
03/12/2003EP0845984B1 Use of aminoadamantane compounds as immunoregulators
03/12/2003EP0763039B1 42-rapamycin hydroxyester, process for its preparation and pharmaceutical compositions containing it
03/12/2003EP0758243B1 BINDING OF E-SELECTIN, P-SELECTIN OR L-SELECTIN TO SIALYL-LEWISx OR SIALYL-LEWISa
03/12/2003EP0705339B1 Human cell adhesion protein aamp-1 and uses thereof
03/12/2003EP0661969B1 Taxol for treating lymphomas and breast cancer and for reducing multi-drug resistance to taxol
03/12/2003CN1402782A MAGE-A12 antigenic peptides and uses thereof
03/12/2003CN1402733A Angiogenic proteins and uses thereof
03/12/2003CN1402722A Arylamine derivs. and their use an anti-telomerase
03/12/2003CN1402721A Benzoimidazole derivs. useful as antiproliferative agents
03/12/2003CN1402720A 2,4-diaminopyrimidine compounds useful as immunosuppressants
03/12/2003CN1402643A Integrin-mediated drug targeting
03/12/2003CN1402640A Stabilized liquid polypeptide-confg. pharmaceutical compositions
03/12/2003CN1401778A Recombinant of viral vector and human tumor suppressor gene, and use thereof
03/12/2003CN1401653A Scrophularia oligose, production method and use thereof
03/12/2003CN1401392A Liver cancer superantigen immunogene therapy agent
03/12/2003CN1401390A Immunoregulation medicine-antibody poietins, preparing process and use thereof
03/12/2003CN1401387A Tumor suppressing polypeptide TSF and gene therapy vector composition
03/12/2003CN1401374A Semifluid motherwort extract and producing process thereof
03/12/2003CN1401349A Formulation of tumor treating capsule, and inspecting method thereof
03/12/2003CN1401317A Use of bismuth subgallate in suppressing formation of nitrogen oxide synthetase
03/12/2003CN1102932C Novel water-soluble analogues of 20(S)-camptothecin, preparing method and use thereof
03/12/2003CN1102853C Tumor metastasis suppressing agent and veterinary tumor metastasis suppressing agent
03/11/2003US6531612 Nitrile derivatives that inhibit cathepsin K
03/11/2003US6531611 Process for making taxane derivatives
03/11/2003US6531610 Intermediate acylating carbonate
03/11/2003US6531598 Naphthostyrils
03/11/2003US6531580 Anti-αvβ3 recombinant human antibodies and nucleic acids encoding same
03/11/2003US6531498 Antiallergens, etc
03/11/2003US6531497 Epothilone derivatives and their synthesis and use
03/11/2003US6531492 Heterocyclo-alkylsulfonyl pyrazole derivatives as anti-inflammatory/analgesic agents
03/11/2003US6531479 Anti-cancer compounds
03/11/2003US6531477 Treating cancer or other proliferative diseases
03/11/2003US6531474 Inhibitors of caspases
03/11/2003US6531472 Tetralone derivatives
03/11/2003US6531456 Gene therapy for the treatment of solid tumors using recombinant adeno-associated virus vectors
03/11/2003US6531451 Isolated antigenic peptide consisting of specified amino acid sequence
03/11/2003US6531450 Use treating neuropathological situations caused by the aging of the nervous system; MP52, MP121 are growth or/and differentiation factors of the TGF-beta (transforming growth factor) superfamily
03/11/2003US6531449 Hexahydropyrazolo[4,3,-c]pyridine metabolites
03/11/2003US6531313 Invasive bacterial vectors for expressing alphavirus replicons
03/11/2003US6531312 Isolated nucleic acid of given sequence
03/11/2003US6531129 Heparanase specific molecular probes and their use in research and medical applications
03/11/2003US6531127 Useful for diagnostic purposes for identifying specific antibodies against human papillomavirus 16 E1 or E2 protein, which contains polypeptides with specific amino acid sequece
03/11/2003CA2146250C Process for preparing taxane derivatives
03/11/2003CA2146155C Process for preparing taxane derivatives
03/10/2003CA2401358A1 Diacid-substituted heteroaryl derivatives as matrix metalloproteinase inhibitors
03/07/2003WO2002020472A1 Substituted phenylcyclohexane carboxylic acid amides and the use thereof
03/07/2003CA2421781A1 Substituted phenylcyclohexane carboxylic acid amides and the use thereof
03/06/2003WO2003019146A2 High throughput screening assays using fatty acid synthetic enzymes
03/06/2003WO2003018842A1 Novel gene nedl-1
03/06/2003WO2003018840A1 Method of evaluating degree of canceration of mammal-origin specimen
03/06/2003WO2003018820A2 Mutant recombinant adeno-associated viruses related applications
03/06/2003WO2003018806A1 Novel human bmcc1 gene
03/06/2003WO2003018804A1 Proteins having effects of controlling cell migration and cell death
03/06/2003WO2003018793A1 Novel gene having guanine nucleotide exchange factor-like sequence
03/06/2003WO2003018788A2 Improved nitroreductase enzymes
03/06/2003WO2003018784A1 Process for producing antigen-specific human t cells and drugs
03/06/2003WO2003018770A2 Amplified oncogenes and their involvement in cancer
03/06/2003WO2003018768A2 Transmembrane protein differentially expressed in cancer
03/06/2003WO2003018759A2 Phenylalanine ammonia lyase polypeptide and polynucleotide sequences and methods of obtaining and using same
03/06/2003WO2003018758A2 Reagents and methods for smooth muscle therapies
03/06/2003WO2003018756A2 Methods for preparing purified prostaglandin e synthase
03/06/2003WO2003018755A2 Wild-type ras as a cancer therapeutic agent
03/06/2003WO2003018742A2 Recombinant l-asparaginase erwinia caratovora
03/06/2003WO2003018640A2 Use of heparinoid derivatives for treating and diagnosing diseases that can be treated by heparinoids
03/06/2003WO2003018635A1 Human cdr-grafted antibodies and antibody fragments thereof
03/06/2003WO2003018632A2 Epitope regions of a thyrotrophin (tsh) receptor, uses thereof and antibodies thereto
03/06/2003WO2003018630A1 Nucleic acid and polypeptide linked to breast cancer and uses therefor
03/06/2003WO2003018612A2 Extracellular messengers
03/06/2003WO2003018611A2 Proaerolysin containing protease activation sequences and methods of use for treatment of prostate cancer
03/06/2003WO2003018606A2 Casein derived peptides and uses thereof in therapy
03/06/2003WO2003018598A2 Monosaccharide derivatives
03/06/2003WO2003018594A1 Targeted bisplatinum polyamines as pro-drugs: selective release of platinum
03/06/2003WO2003018593A2 Platinum(ii)- and platinum(iv)-complexes and their use
1 ... 1593 1594 1595 1596 1597 1598 1599 1600 1601 1602 1603 1604 1605 1606 1607 1608 1609 1610 1611 1612 1613 ... 2211